Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Latest FIGO staging for cervical carcinoma

Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse...

Latest FIGO staging for cervical carcinoma ( Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France )

PARP inhibitors and immunotherapy in ovarian cancer: From research to practice

PARP inhibitors and immunotherapy in ovarian cancer: From research to practice ( )

The age of genomic profiling

Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey

The age of genomic profiling ( Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey )

Identifying BRCA mutations for breast and ovarian cancer

Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus

Identifying BRCA mutations for breast and ovarian cancer ( Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus )

AORTIC working with BGICS for better cancer care in Africa

Prof Abubakar Mohammed Bello - President, AORTIC

AORTIC working with BGICS for better cancer care in Africa ( Prof Abubakar Mohammed Bello - President, AORTIC )

Patient quality of life in adult ALL

Zack Pemberton-Whiteley (UK)

Patient quality of life in adult ALL ( Zack Pemberton-Whiteley (UK) )

CAR-T cell therapy for ALL: Current challenges and future approaches

Dr Sara Ghorashian - University College London, London, UK

CAR-T cell therapy for ALL: Current challenges and future approaches ( Dr Sara Ghorashian - University College London, London, UK )

Considerations for treatment sequencing in B-ALL

Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany

Considerations for treatment sequencing in B-ALL ( Prof Nicola Gökbuget - Universitätsklinikum Frankfurt, Frankfurt, Germany )

CART-T cell therapy in young patients with relapsed/refractory ALL

Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany

$CART-T cell therapy in young patients with relapsed/refractory ALL ( Prof Peter Bader - Universitätsklinikum Frankfurt, Frankfurt, Germany )$

HSCT: Donor selection for patients with ALL

Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology...

HSCT: Donor selection for patients with ALL ( Prof Sebastian Giebel - The Maria Skłodowska-Curie Institute of Oncology, Gliwice, Poland )

Therapy of Ph-positive adult ALL

Prof Oliver Ottmann - Cardiff University, Cardiff, UK

Therapy of Ph-positive adult ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )

The role of blinatumomab followed by HSCT in paediatric patients with ALL

Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy

The role of blinatumomab followed by HSCT in paediatric patients with ALL ( Prof Franco Locatelli - Ospedale Pediatrico Bambino Gesù, Rome, Italy )

More from ecancer